PerkinElmer Aktie

104,71USD 1,92USD 1,87%
PerkinElmer für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN: 850943 / ISIN: US7140461093

<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
<
Aktion
Portfolio
Watchlist
>

Personal

2021 2022 2023 2024 2025
Personal am Ende des Jahres 16 700 16 700 11 500 11 000 0
Umsatz pro Mitarbeiter in Mio. EUR 0,30 0,20 0,24 0,25 0,00

Bilanz (in Mio. USD) - Aktiva

2021 2022 2023 2024 2025
Summe Umlaufvermögen 2 441 3 289 3 001 2 350 2 240
Summe Anlagevermögen 12 560 10 841 10 564 10 043 9 929
Summe Aktiva 15 001 14 130 13 565 12 392 12 168

Bilanz (in Mio. USD) - Passiva

2021 2022 2023 2024 2025
Summe Fremdkapital 7 859 6 747 5 692 4 726 4 918
Summe Eigenkapital 7 141 7 383 7 873 7 667 7 250
Summe Passiva 15 001 14 130 13 565 12 392 12 168

Adresse

77 Citypoint 4th Avenue, 02451 Waltham
Telefon +1 (781) 663-6900
Internet http://www.revvity.com

Management

Alexis Platon Michas
Independent Non-Executive Chairman
Anita Gonzales
Chief Accounting Officer & Vice President
Arvind Sundar Rajan
Senior VP, Chief Digital & Strategy Officer
Bryan A. Kipp
Senior Vice President-Technology & Licensing
Franklin R. Witney
Independent Director
Jayashree Kailas Thacker
Chief Automation Officer & Senior Vice President
Joel S. Goldberg
Secretary, SVP-Administration & General Counsel
Madhuri Hegde
Chief Scientific Officer & Senior Vice President
Magali Four
Chief People & Culture Officer & SVP
Maxwell Krakowiak
Chief Financial Officer & Senior Vice President
Michael A. Klobuchar
Independent Director
Michel Pericles Vounatsos
Independent Director
Michelle McMurry-Heath
Independent Director
Miriame Victor
Chief Commercial Officer & Senior Vice President
Pascale Witz
Independent Non-Executive Director
Peter Barrett
Independent Director
Prahlad Ramadhar Singh
President, Chief Executive Officer & Director
Samuel Ross Chapin
Independent Director
Sophie V. Vandebroek
Independent Director
Steve Willoughby
Vice President-Investor Relations
Tajinder S. Vohra
Senior Vice President-Global Operations
Yi Ping Lin
Chief Quality, Regulatory & Clinical Officer